A Japanese government health panel announced on Friday that it approved the usage of Pfizer-BioNTech coronavirus vaccine, Reuters reported, citing Japan's national television NHK.
"Prime Minister Yoshihide Suga has said vaccinations would begin from the middle of next week, starting with some 10,000 health workers," Reuters added.
This development doesn't seem to be having a significant impact on the Japanese yen's performance against its major rivals. As of writing, the USD/JPY pair was trading at 105.02, where it was up 0.3% on a daily basis.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.